We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Role of Positive Affect in Adjustment to HIV (CHAI)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00582023
First Posted: December 28, 2007
Last Update Posted: November 25, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
National Institute of Mental Health (NIMH)
Information provided by (Responsible Party):
University of California, San Francisco
  Purpose
The purpose of this study is to examine the role of emotion and mood in the context of HIV.

Condition
HIV Infections

Study Type: Observational
Study Design: Observational Model: Cohort
Official Title: CHAI Study: Coping, HIV, and Affect Interview Study

Resource links provided by NLM:


Further study details as provided by University of California, San Francisco:

Primary Outcome Measures:
  • Well being [ Time Frame: 18 month follow-up ]
  • Physical & Mental Health [ Time Frame: 18 months ]
  • Coping Response [ Time Frame: 18 months ]

Enrollment: 160
Study Start Date: September 2004
Study Completion Date: June 2012
Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)
Detailed Description:
A growing body of literature indicates that positive affect may have a unique adaptive role in the process of adjustment to chronic stress, independent of the effects of negative affects like depression. The overarching goal of this research is to provide evidence and direction for the development of interventions for people with HIV that include a focus on positive affect. To this end, this study will document the occurrence, predictors, and consequences of positive affect during the 18 months post-notification of HIV+ serostatus.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Adults newly diagnosed with HIV in the San Franicsco Bay Area.
Criteria

Inclusion Criteria:

  • Have been informed they were HIV positive within the past two months
  • Speak English
  • Be 18 years or older
  • Have the ability to provide informed consent to be a research participant

Exclusion Criteria:

  • Severe cognitive impairment
  • Active psychosis
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00582023


Locations
United States, California
Osher Center for Integrative Medicine, UCSF
San Francisco, California, United States, 94115
Sponsors and Collaborators
University of California, San Francisco
National Institute of Mental Health (NIMH)
Investigators
Principal Investigator: Judith Moskowitz, PhD, MPH University of California, San Francisco
  More Information

Responsible Party: University of California, San Francisco
ClinicalTrials.gov Identifier: NCT00582023     History of Changes
Other Study ID Numbers: CHAI 971423990
R01MH068170 ( U.S. NIH Grant/Contract )
First Submitted: December 19, 2007
First Posted: December 28, 2007
Last Update Posted: November 25, 2013
Last Verified: November 2013

Keywords provided by University of California, San Francisco:
HIV
coping
emotion
affect
HIV infection
Complimentary therapies

Additional relevant MeSH terms:
HIV Infections
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Virus Diseases
Sexually Transmitted Diseases, Viral
Sexually Transmitted Diseases
Immunologic Deficiency Syndromes
Immune System Diseases